Cargando…

Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease

PURPOSE: Hyperhomocysteinemia is an independent risk factor for cardio- and cerebrovascular diseases. However, the relationship between plasma homocysteine (Hcy) concentration and peripheral arterial disease (PAD) has not been completely characterized. The aim of the present study was to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mengyuan, Fan, Fangfang, Liu, Bo, Jia, Jia, Jiang, Yimeng, Sun, Pengfei, He, Danmei, Liu, Jiahui, Li, Yuxi, Huo, Yong, Li, Jianping, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532045/
https://www.ncbi.nlm.nih.gov/pubmed/33061499
http://dx.doi.org/10.2147/DMSO.S267122
_version_ 1783589842036195328
author Liu, Mengyuan
Fan, Fangfang
Liu, Bo
Jia, Jia
Jiang, Yimeng
Sun, Pengfei
He, Danmei
Liu, Jiahui
Li, Yuxi
Huo, Yong
Li, Jianping
Zhang, Yan
author_facet Liu, Mengyuan
Fan, Fangfang
Liu, Bo
Jia, Jia
Jiang, Yimeng
Sun, Pengfei
He, Danmei
Liu, Jiahui
Li, Yuxi
Huo, Yong
Li, Jianping
Zhang, Yan
author_sort Liu, Mengyuan
collection PubMed
description PURPOSE: Hyperhomocysteinemia is an independent risk factor for cardio- and cerebrovascular diseases. However, the relationship between plasma homocysteine (Hcy) concentration and peripheral arterial disease (PAD) has not been completely characterized. The aim of the present study was to determine the relationship between plasma Hcy concentration and new-onset PAD and to assess the effects of combinations of Hcy and traditional cardiovascular risk factors. PATIENTS AND METHODS: We conducted a prospective community-based cohort study of 3119 Chinese participants who did not have PAD at baseline, with a median follow-up period of 2.30 years. We used multivariate logistic regression models to evaluate the relationship between high Hcy (≥10µmol/L) and new-onset PAD. The effects of combinations of high Hcy and traditional cardiovascular risk factors were assessed using logistic regression analysis. RESULTS: After adjustment for 14 covariates, high Hcy concentration was significantly associated with new-onset PAD (odds ratio [OR]=2.08, 95% confidence interval [CI]: 1.08–4.03, P=0.030). Smokers with high Hcy concentration were substantially more likely to have new-onset PAD than non-smokers with normal Hcy concentration (OR=4.44, 95% CI: 1.77–11.12, P=0.001). The effect of diabetes on PAD became significant when present in combination with high Hcy concentration (OR=3.67, 95% CI: 1.25–10.80, P=0.018). Participants with both elevated Hcy levels and older age had the highest risk of new-onset PAD (OR=4.28, 95% CI: 1.83–10.01, P<0.001). With regard to the joint effect of Hcy and hypertension, dyslipidemia or sex, there was also a trend towards increased risk across four different groups (P for trend=0.026, 0.035, 0.016, respectively). CONCLUSION: High plasma Hcy concentration independently predicts the incidence of PAD. Furthermore, there is a joint effect of high Hcy concentration and traditional cardiovascular risk factors such as smoking, diabetes and aging on the incidence of PAD.
format Online
Article
Text
id pubmed-7532045
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75320452020-10-14 Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease Liu, Mengyuan Fan, Fangfang Liu, Bo Jia, Jia Jiang, Yimeng Sun, Pengfei He, Danmei Liu, Jiahui Li, Yuxi Huo, Yong Li, Jianping Zhang, Yan Diabetes Metab Syndr Obes Original Research PURPOSE: Hyperhomocysteinemia is an independent risk factor for cardio- and cerebrovascular diseases. However, the relationship between plasma homocysteine (Hcy) concentration and peripheral arterial disease (PAD) has not been completely characterized. The aim of the present study was to determine the relationship between plasma Hcy concentration and new-onset PAD and to assess the effects of combinations of Hcy and traditional cardiovascular risk factors. PATIENTS AND METHODS: We conducted a prospective community-based cohort study of 3119 Chinese participants who did not have PAD at baseline, with a median follow-up period of 2.30 years. We used multivariate logistic regression models to evaluate the relationship between high Hcy (≥10µmol/L) and new-onset PAD. The effects of combinations of high Hcy and traditional cardiovascular risk factors were assessed using logistic regression analysis. RESULTS: After adjustment for 14 covariates, high Hcy concentration was significantly associated with new-onset PAD (odds ratio [OR]=2.08, 95% confidence interval [CI]: 1.08–4.03, P=0.030). Smokers with high Hcy concentration were substantially more likely to have new-onset PAD than non-smokers with normal Hcy concentration (OR=4.44, 95% CI: 1.77–11.12, P=0.001). The effect of diabetes on PAD became significant when present in combination with high Hcy concentration (OR=3.67, 95% CI: 1.25–10.80, P=0.018). Participants with both elevated Hcy levels and older age had the highest risk of new-onset PAD (OR=4.28, 95% CI: 1.83–10.01, P<0.001). With regard to the joint effect of Hcy and hypertension, dyslipidemia or sex, there was also a trend towards increased risk across four different groups (P for trend=0.026, 0.035, 0.016, respectively). CONCLUSION: High plasma Hcy concentration independently predicts the incidence of PAD. Furthermore, there is a joint effect of high Hcy concentration and traditional cardiovascular risk factors such as smoking, diabetes and aging on the incidence of PAD. Dove 2020-09-28 /pmc/articles/PMC7532045/ /pubmed/33061499 http://dx.doi.org/10.2147/DMSO.S267122 Text en © 2020 Liu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Mengyuan
Fan, Fangfang
Liu, Bo
Jia, Jia
Jiang, Yimeng
Sun, Pengfei
He, Danmei
Liu, Jiahui
Li, Yuxi
Huo, Yong
Li, Jianping
Zhang, Yan
Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
title Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
title_full Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
title_fullStr Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
title_full_unstemmed Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
title_short Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
title_sort joint effects of plasma homocysteine concentration and traditional cardiovascular risk factors on the risk of new-onset peripheral arterial disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532045/
https://www.ncbi.nlm.nih.gov/pubmed/33061499
http://dx.doi.org/10.2147/DMSO.S267122
work_keys_str_mv AT liumengyuan jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT fanfangfang jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT liubo jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT jiajia jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT jiangyimeng jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT sunpengfei jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT hedanmei jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT liujiahui jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT liyuxi jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT huoyong jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT lijianping jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease
AT zhangyan jointeffectsofplasmahomocysteineconcentrationandtraditionalcardiovascularriskfactorsontheriskofnewonsetperipheralarterialdisease